3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Hyperglycemia
1
Hereditary Sensory and Autonomic Neuropathies
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus
1
Breast Neoplasms
1
Interventions
relacorilant
1
pembrolizumab
1
dapagliflozin
1
Fulvestrant
1
Alpelisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Hyperglycemia
×
dapagliflozin
×
Clear all
NCT04899349
2024-10-09
EPIK-B4
Novartis
Phase 2
Terminated
2 enrolled
8 charts